(Q46812072)

25 December 2017

title

Late intervention with a myeloperoxidase inhibitor stops progression of experimental chronic obstructive pulmonary disease (English)

1 reference

25 December 2017

chronic obstructive pulmonary disease

main subject

1 reference

Andrew Churg

1

1 reference

25 December 2017

Caroline V Marshall

2

1 reference

25 December 2017

Don D Sin

3

1 reference

25 December 2017

Sarah Bolton

4

1 reference

25 December 2017

Steven Zhou

5

1 reference

25 December 2017

Katherine Thain

6

1 reference

25 December 2017

Elaine B Cadogan

7

1 reference

25 December 2017

Justine Maltby

8

1 reference

25 December 2017

Matthew G Soars

9

1 reference

25 December 2017

Philip R Mallinder

10

1 reference

25 December 2017

Joanne L Wright

11

1 reference

25 December 2017

language of work or name

English

0 references

publication date

1 January 2012

1 reference

25 December 2017

American Journal of Respiratory and Critical Care Medicine

published in

1 reference

25 December 2017

volume

185

1 reference

25 December 2017

issue

1

1 reference

25 December 2017

page(s)

34-43

1 reference

25 December 2017

Trends in the leading causes of death in the United States, 1970-2002.

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0468OC

The epidemiology and economics of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0468OC

Mechanisms of cigarette smoke-induced COPD: insights from animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0468OC

Myeloperoxidase: molecular mechanisms of action and their relevance to human health and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0468OC

3-Chlorotyrosine in sputum of COPD patients: relationship with airway inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0468OC

Tyrosyl radical production by myeloperoxidase: a phagocyte pathway for lipid peroxidation and dityrosine cross-linking of proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0468OC

Free-radical chemistry of cigarette smoke and its toxicological implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0468OC

Is oxidative stress central to the pathogenesis of chronic obstructive pulmonary disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0468OC

Antioxidant therapeutic advances in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0468OC

Cellular response to cigarette smoke and oxidants: adapting to survive

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0468OC

Superoxide dismutase expression attenuates cigarette smoke- or elastase-generated emphysema in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0468OC

Extracellular superoxide dismutase protects against pulmonary emphysema by attenuating oxidative fragmentation of ECM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0468OC

Curcumin attenuates elastase- and cigarette smoke-induced pulmonary emphysema in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0468OC

Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0468OC

Rtp801, a suppressor of mTOR signaling, is an essential mediator of cigarette smoke-induced pulmonary injury and emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0468OC

Redox regulation of lung inflammation: role of NADPH oxidase and NF-kappaB signalling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0468OC

NADPH oxidase restrains the matrix metalloproteinase activity of macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0468OC

The myeloperoxidase system of human phagocytes generates Nepsilon-(carboxymethyl)lysine on proteins: a mechanism for producing advanced glycation end products at sites of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0468OC

RAGE: developmental expression and positive feedback regulation by Egr-1 during cigarette smoke exposure in pulmonary epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0468OC

Asbestos-induced lung inflammation and epithelial cell proliferation are altered in myeloperoxidase-null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0468OC

CD8+ T Cells are required for inflammation and destruction in cigarette smoke-induced emphysema in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0468OC

Neutrophil elastase contributes to cigarette smoke-induced emphysema in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0468OC

Statin reverses smoke-induced pulmonary hypertension and prevents emphysema but not airway remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0468OC

Serum myeloperoxidase levels independently predict endothelial dysfunction in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0468OC

Roflumilast fully prevents emphysema in mice chronically exposed to cigarette smoke

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0468OC

Tumor necrosis factor-alpha drives 70% of cigarette smoke-induced emphysema in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0468OC

Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0468OC

Pharmacological characterisation of anti-inflammatory compounds in acute and chronic mouse models of cigarette smoke-induced inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0468OC

Clarithromycin prevents smoke-induced emphysema in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0468OC

Simvastatin attenuates experimental small airway remodelling in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0468OC

Pitfalls in antiprotease therapy of emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0468OC

Treatment of COPD: the sooner the better?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0468OC

10.1164/RCCM.201103-0468OC

21 January 2018

Identifiers

DOI

1 reference

25 December 2017

release_qkv4ne4475dqzbwqvgvzd3onrm

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/qkv4ne4475dqzbwqvgvzd3onrm

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

25 December 2017